 | • レポートコード：GIR-105X13059 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、変形性関節症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。変形性関節症治療薬の種類別市場規模（経口、注射、外用）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・変形性関節症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Pfizer、Eli Lilly、Abbott、GlaxoSmithKline、Sanofi、Flexion Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射、外用 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・変形性関節症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・変形性関節症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・変形性関節症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・変形性関節症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・変形性関節症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Osteoarthritis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Osteoarthritis Drugs size is estimated to be xx million in 2020 from USD 5541.9 million in 2019, with a change of XX% between 2019 and 2020. The global Osteoarthritis Drugs market size is expected to grow at a CAGR of 4.3% for the next five years.
Market segmentation
Osteoarthritis Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
External
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Osteoarthritis Drugs market are listed below:
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Osteoarthritis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Osteoarthritis Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Osteoarthritis Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Osteoarthritis Drugs Market Size & Forecast
1.4.1 Global Osteoarthritis Drugs Sales in Value (2016-2026))
1.4.2 Global Osteoarthritis Drugs Sales in Volume (2016-2026)
1.4.3 Global Osteoarthritis Drugs Price by Type (2016-2026) & (USD/Kg)
1.5 Global Osteoarthritis Drugs Production Capacity Analysis
1.5.1 Global Osteoarthritis Drugs Total Production Capacity (2016-2026)
1.5.2 Global Osteoarthritis Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Osteoarthritis Drugs Market Drivers
1.6.2 Osteoarthritis Drugs Market Restraints
1.6.3 Osteoarthritis Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Osteoarthritis Drugs Product and Services
2.1.4 Johnson & Johnson Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Osteoarthritis Drugs Product and Services
2.2.4 Pfizer Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Osteoarthritis Drugs Product and Services
2.3.4 Eli Lilly Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Osteoarthritis Drugs Product and Services
2.4.4 Abbott Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Osteoarthritis Drugs Product and Services
2.5.4 GlaxoSmithKline Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Osteoarthritis Drugs Product and Services
2.6.4 Sanofi Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Flexion Therapeutics
2.7.1 Flexion Therapeutics Details
2.7.2 Flexion Therapeutics Major Business
2.7.3 Flexion Therapeutics Osteoarthritis Drugs Product and Services
2.7.4 Flexion Therapeutics Osteoarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Osteoarthritis Drugs Sales by Manufacturer
3.1 Global Osteoarthritis Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Osteoarthritis Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Osteoarthritis Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Osteoarthritis Drugs Manufacturer Market Share
3.4.2 Top 6 Osteoarthritis Drugs Manufacturer Market Share
3.5 Global Osteoarthritis Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Osteoarthritis Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Osteoarthritis Drugs Market Size by Region
4.1.1 Global Osteoarthritis Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Osteoarthritis Drugs Revenue by Region (2016-2026)
4.2 North America Osteoarthritis Drugs Revenue (2016-2026)
4.3 Europe Osteoarthritis Drugs Revenue (2016-2026)
4.4 Asia-Pacific Osteoarthritis Drugs Revenue (2016-2026)
4.5 South America Osteoarthritis Drugs Revenue (2016-2026)
4.6 Middle East and Africa Osteoarthritis Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Osteoarthritis Drugs Sales in Volume by Type (2016-2026)
5.2 Global Osteoarthritis Drugs Revenue by Type (2016-2026)
5.3 Global Osteoarthritis Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Osteoarthritis Drugs Sales in Volume by Application (2016-2026)
6.2 Global Osteoarthritis Drugs Revenue by Application (2016-2026)
6.3 Global Osteoarthritis Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Osteoarthritis Drugs Sales by Type (2016-2026)
7.2 North America Osteoarthritis Drugs Sales by Application (2016-2026)
7.3 North America Osteoarthritis Drugs Market Size by Country
7.3.1 North America Osteoarthritis Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Osteoarthritis Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Osteoarthritis Drugs Sales by Type (2016-2026)
8.2 Europe Osteoarthritis Drugs Sales by Application (2016-2026)
8.3 Europe Osteoarthritis Drugs Market Size by Country
8.3.1 Europe Osteoarthritis Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Osteoarthritis Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Osteoarthritis Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Osteoarthritis Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Osteoarthritis Drugs Market Size by Region
9.3.1 Asia-Pacific Osteoarthritis Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Osteoarthritis Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Osteoarthritis Drugs Sales by Type (2016-2026)
10.2 South America Osteoarthritis Drugs Sales by Application (2016-2026)
10.3 South America Osteoarthritis Drugs Market Size by Country
10.3.1 South America Osteoarthritis Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Osteoarthritis Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Osteoarthritis Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Osteoarthritis Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Osteoarthritis Drugs Market Size by Country
11.3.1 Middle East & Africa Osteoarthritis Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Osteoarthritis Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Osteoarthritis Drugs Typical Distributors
12.3 Osteoarthritis Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Osteoarthritis Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Osteoarthritis Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Osteoarthritis Drugs Product and Services
Table 6. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Osteoarthritis Drugs Product and Services
Table 10. Pfizer Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly Osteoarthritis Drugs Product and Services
Table 14. Eli Lilly Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Osteoarthritis Drugs Product and Services
Table 18. Abbott Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Osteoarthritis Drugs Product and Services
Table 22. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Osteoarthritis Drugs Product and Services
Table 26. Sanofi Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Flexion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Flexion Therapeutics Major Business
Table 29. Flexion Therapeutics Osteoarthritis Drugs Product and Services
Table 30. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Osteoarthritis Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 32. Global Osteoarthritis Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Osteoarthritis Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Osteoarthritis Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 35. Head Office and Osteoarthritis Drugs Production Site of Key Manufacturer
Table 36. Global Osteoarthritis Drugs Sales by Region (2016-2021e) & (MT)
Table 37. Global Osteoarthritis Drugs Sales by Region (2021-2026) & (MT)
Table 38. Global Osteoarthritis Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Osteoarthritis Drugs Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Osteoarthritis Drugs Sales by Type (2016-2021e) & (MT)
Table 41. Global Osteoarthritis Drugs Sales by Type (2021-2026) & (MT)
Table 42. Global Osteoarthritis Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Osteoarthritis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Osteoarthritis Drugs Price by Type (2016-2021e) & (USD/Kg)
Table 45. Global Osteoarthritis Drugs Price by Type (2021-2026) & (USD/Kg)
Table 46. Global Osteoarthritis Drugs Sales by Application (2016-2021e) & (MT)
Table 47. Global Osteoarthritis Drugs Sales by Application (2021-2026) & (MT)
Table 48. Global Osteoarthritis Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Osteoarthritis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Osteoarthritis Drugs Price by Application (2016-2021e) & (USD/Kg)
Table 51. Global Osteoarthritis Drugs Price by Application (2021-2026) & (USD/Kg)
Table 52. North America Osteoarthritis Drugs Sales by Country (2016-2021e) & (MT)
Table 53. North America Osteoarthritis Drugs Sales by Country (2021-2026) & (MT)
Table 54. North America Osteoarthritis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Osteoarthritis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Osteoarthritis Drugs Sales by Type (2016-2021e) & (MT)
Table 57. North America Osteoarthritis Drugs Sales by Type (2021-2026) & (MT)
Table 58. North America Osteoarthritis Drugs Sales by Application (2016-2021e) & (MT)
Table 59. North America Osteoarthritis Drugs Sales by Application (2021-2026) & (MT)
Table 60. Europe Osteoarthritis Drugs Sales by Country (2016-2021e) & (MT)
Table 61. Europe Osteoarthritis Drugs Sales by Country (2021-2026) & (MT)
Table 62. Europe Osteoarthritis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Osteoarthritis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Osteoarthritis Drugs Sales by Type (2016-2021e) & (MT)
Table 65. Europe Osteoarthritis Drugs Sales by Type (2021-2026) & (MT)
Table 66. Europe Osteoarthritis Drugs Sales by Application (2016-2021e) & (MT)
Table 67. Europe Osteoarthritis Drugs Sales by Application (2021-2026) & (MT)
Table 68. Asia-Pacific Osteoarthritis Drugs Sales by Region (2016-2021e) & (MT)
Table 69. Asia-Pacific Osteoarthritis Drugs Sales by Region (2021-2026) & (MT)
Table 70. Asia-Pacific Osteoarthritis Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Osteoarthritis Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Osteoarthritis Drugs Sales by Type (2016-2021e) & (MT)
Table 73. Asia-Pacific Osteoarthritis Drugs Sales by Type (2021-2026) & (MT)
Table 74. Asia-Pacific Osteoarthritis Drugs Sales by Application (2016-2021e) & (MT)
Table 75. Asia-Pacific Osteoarthritis Drugs Sales by Application (2021-2026) & (MT)
Table 76. South America Osteoarthritis Drugs Sales by Country (2016-2021e) & (MT)
Table 77. South America Osteoarthritis Drugs Sales by Country (2021-2026) & (MT)
Table 78. South America Osteoarthritis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Osteoarthritis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Osteoarthritis Drugs Sales by Type (2016-2021e) & (MT)
Table 81. South America Osteoarthritis Drugs Sales by Type (2021-2026) & (MT)
Table 82. South America Osteoarthritis Drugs Sales by Application (2016-2021e) & (MT)
Table 83. South America Osteoarthritis Drugs Sales by Application (2021-2026) & (MT)
Table 84. Middle East & Africa Osteoarthritis Drugs Sales by Country (2016-2021e) & (MT)
Table 85. Middle East & Africa Osteoarthritis Drugs Sales by Country (2021-2026) & (MT)
Table 86. Middle East & Africa Osteoarthritis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Osteoarthritis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Osteoarthritis Drugs Sales by Type (2016-2021e) & (MT)
Table 89. Middle East & Africa Osteoarthritis Drugs Sales by Type (2021-2026) & (MT)
Table 90. Middle East & Africa Osteoarthritis Drugs Sales by Application (2016-2021e) & (MT)
Table 91. Middle East & Africa Osteoarthritis Drugs Sales by Application (2021-2026) & (MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Osteoarthritis Drugs Typical Distributors
Table 95. Osteoarthritis Drugs Typical Customers
List of Figures
Figure 1. Osteoarthritis Drugs Picture
Figure 2. Global Osteoarthritis Drugs Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. External
Figure 6. Global Osteoarthritis Drugs Sales Market Share by Application in 2020
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Osteoarthritis Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Osteoarthritis Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Osteoarthritis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Osteoarthritis Drugs Sales (2016-2026) & (MT)
Figure 32. Global Osteoarthritis Drugs Production Capacity (2016-2026) & (MT)
Figure 33. Global Osteoarthritis Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Osteoarthritis Drugs Market Drivers
Figure 35. Osteoarthritis Drugs Market Restraints
Figure 36. Osteoarthritis Drugs Market Trends
Figure 37. Global Osteoarthritis Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Osteoarthritis Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Osteoarthritis Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Osteoarthritis Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Osteoarthritis Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Osteoarthritis Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Osteoarthritis Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Osteoarthritis Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Osteoarthritis Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Osteoarthritis Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Osteoarthritis Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Osteoarthritis Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Osteoarthritis Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Osteoarthritis Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 52. Global Osteoarthritis Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Osteoarthritis Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Osteoarthritis Drugs Price by Application (2016-2026) & (USD/Kg)
Figure 55. North America Osteoarthritis Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Osteoarthritis Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Osteoarthritis Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Osteoarthritis Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Osteoarthritis Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Osteoarthritis Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Osteoarthritis Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Osteoarthritis Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Osteoarthritis Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Osteoarthritis Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Osteoarthritis Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Osteoarthritis Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Osteoarthritis Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Osteoarthritis Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Osteoarthritis Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Osteoarthritis Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Osteoarthritis Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
変形性関節症の治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…- 骨関節炎痛用薬の世界市場2018-2025 Medicine for Osteoarthritis Pain is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Medicine for Osteoarthritis Pain market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.7% from 2018. In this study, 2017 has been consider…
- 変形性関節症用痛み止めの世界市場2018-2025 Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Osteoarthritis Pain Medicine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.7% from 2018. In this study, 2017 has been considered as th…
- 変形性関節症用ソリューションの世界市場2018-2025 Osteoarthritis Pain Solution is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Osteoarthritis Pain Solution market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.7% from 2018. In this study, 2017 has been considered as th…
- 骨関節炎鎮痛剤の世界市場2018-2025 Hip Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Hip Osteoarthritis Pain Medicine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.5% from 2018. In this study, 2017 has been consider…